← All organizations
Highest phase reached
Phase 3
First clinical trial
Feb 24, 2017Last known activity
Dec 11, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (7 distinct, 4 trials)
Phase 3 (6 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (4)
- NCT07276282OfficialPhase 3Dec 11, 2025
- NCT06640777CollaboratorPhase 3Nov 1, 2024
- NCT03023020CollaboratorN/AApr 4, 2017
- NCT02866175CollaboratorPhase 3Feb 24, 2017
Details
- Last known activity
- Dec 11, 2025